DAPK1 interacts with NMDAR and involves in glutamate-induced neurological events, such as stroke. Inhibiting DAPK1 can lead to phosphorylation and surface normalization of GluN2B expression outside the synapse. The gene discussed is GRIN2B; the disease is stroke disorder.